IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy

Francis E. Lotrich, Jennifer M. Loftis, Robert E. Ferrell, Mordechai Rabinovitz, Peter Hauser

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences